These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18082568

  • 1. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G, Contini P, Setti M, Cagnati P, Villa R, Lantieri F, Indiveri F, Puppo F.
    Hum Immunol; 2007 Nov; 68(11):894-900. PubMed ID: 18082568
    [Abstract] [Full Text] [Related]

  • 2. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G, Contini P, Setti M, Cagnati P, Lantieri F, Indiveri F, Puppo F.
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [Abstract] [Full Text] [Related]

  • 3. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 4. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
    Brumme ZL, Brumme CJ, Chui C, Mo T, Wynhoven B, Woods CK, Henrick BM, Hogg RS, Montaner JS, Harrigan PR.
    J Infect Dis; 2007 Jun 01; 195(11):1694-704. PubMed ID: 17471440
    [Abstract] [Full Text] [Related]

  • 5. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.
    HIV Med; 2007 May 01; 8(4):213-9. PubMed ID: 17461848
    [Abstract] [Full Text] [Related]

  • 6. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K, Altinbaş A, Calik Başaran N, Unal S, Us D, Karabulut E, Ustaçelebi S.
    Mikrobiyol Bul; 2008 Jul 15; 42(3):413-9. PubMed ID: 18822884
    [Abstract] [Full Text] [Related]

  • 9. Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.
    Kitchen CM, Kitchen SG, Dubin JA, Gottlieb MS.
    Clin Infect Dis; 2001 Aug 15; 33(4):466-72. PubMed ID: 11462181
    [Abstract] [Full Text] [Related]

  • 10. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.
    Gaardbo JC, Nielsen SD, Vedel SJ, Ersbøll AK, Harritshøj L, Ryder LP, Nielsen JO, Kolte L.
    Clin Exp Immunol; 2008 Oct 15; 154(1):80-6. PubMed ID: 18821942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
    Montes de Oca Arjona M, Pérez Cano R, Orozco MJ, Martín Aspas A, Guerrero F, Fernández Gutiérrez Del Alamo C, Girón-González JA.
    Clin Microbiol Infect; 2005 Jan 15; 11(1):57-62. PubMed ID: 15649305
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
    Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.
    Scand J Immunol; 2006 Jun 15; 63(6):478-86. PubMed ID: 16764702
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 15; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 17. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
    Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M.
    J Med Virol; 2009 Mar 15; 81(3):400-5. PubMed ID: 19152404
    [Abstract] [Full Text] [Related]

  • 18. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy.
    Orsilles MA, Pieri E, Cooke P, Caula C.
    APMIS; 2006 Jan 15; 114(1):55-60. PubMed ID: 16499662
    [Abstract] [Full Text] [Related]

  • 19. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 15; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 20. Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.
    Knapp DJ, Brumme ZL, Huang SY, Wynhoven B, Dong WW, Mo T, Harrigan PR, Brumme CJ.
    Clin Infect Dis; 2012 Jun 15; 54(11):1652-9. PubMed ID: 22460975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.